A novel marker relationship between carotid intima-media thickness and disease activity score-28 in patients with rheumatoid arthritis: human endothelial cell-specific molecule-1
dc.contributor.author | Tuzcu, Goksel | |
dc.contributor.author | Uslu, Ali Ugur | |
dc.contributor.author | Tuzcu, Ayca | |
dc.contributor.author | Baykara, Rabia Aydogan | |
dc.contributor.author | Omma, Ahmet | |
dc.contributor.author | Kucuk, Adem | |
dc.date.accessioned | 2024-02-23T14:37:23Z | |
dc.date.available | 2024-02-23T14:37:23Z | |
dc.date.issued | 2019 | |
dc.department | NEÜ | en_US |
dc.description.abstract | Background/aim: Human endothelial cell-specific molecule-1 (endocan) is a marker of vascular endothelial dysfunction that may be used in the evaluation of inflammatory-associated atherosclerotic lesions. Endocan may be a marker for the evaluation of atherosclerosis and disease activity in rheumatoid arthritis (RA) patients. Materials and methods: We included 39 RA patients assessed according to the American College of Rheumatology/European League Against Rheumatology 2010 diagnostic criteria and recruited 30 age- and sex-matching healthy subjects for the control group. Results: Endocan values were 14.11 +/- 3.27 for the RA patients and 12.10 +/- 2.92 for the controls. The endocan values of the patients were significantly higher than those of the control group (P = 0.009). In the correlation analysis, endocan showed a significantly positive correlation with disease activity score-28 (r = 0.386, P = 0.029) and carotid intima-media thickness (cIMT) (r = 0.419, P = 0.008). Linear regression analysis revealed that there was an independent relationship between endocan and cIMT (P = 0.029). Conclusion: Endocan can be a marker for early atherosclerosis and disease activity in RA patients. | en_US |
dc.identifier.doi | 10.3906/sag-1806-60 | |
dc.identifier.endpage | 1605 | en_US |
dc.identifier.issn | 1300-0144 | |
dc.identifier.issn | 1303-6165 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 31655533 | en_US |
dc.identifier.scopus | 2-s2.0-85076874589 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 1599 | en_US |
dc.identifier.uri | https://doi.org/10.3906/sag-1806-60 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/16081 | |
dc.identifier.volume | 49 | en_US |
dc.identifier.wos | WOS:000504051300001 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Tubitak Scientific & Technological Research Council Turkey | en_US |
dc.relation.ispartof | Turkish Journal Of Medical Sciences | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Human Endothelial Cell-Specific Molecule-1 | en_US |
dc.subject | Rheumatoid Arthritis | en_US |
dc.subject | Atherosclerosis | en_US |
dc.subject | Carotid Intima-Media Thickness | en_US |
dc.subject | Marker | en_US |
dc.title | A novel marker relationship between carotid intima-media thickness and disease activity score-28 in patients with rheumatoid arthritis: human endothelial cell-specific molecule-1 | en_US |
dc.type | Article | en_US |